Phase Ib study of pembrolizumab and XL888 in patients with advanced colorectal cancer

被引：0
|
作者：
Alese, O. [1 ]
Gbolahan, O. B. [1 ]
McCook-Veal, A. [1 ]
Coleman, K. [1 ]
Greene, E. [1 ]
Horvat, N. [1 ]
Switchenko, J. [1 ]
Lesinski, G. [1 ]
El-Rayes, B. F. [2 ]
机构：
[1] Emory Univ, Winship Canc Inst, Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Hematooncol Dept, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [21] Pembrolizumab (Pembro; MK-3475) for advanced urothelial cancer: Results of a phase IB study.
    O'Donnell, Peter H.
    Plimack, Elizabeth R.
    Bellmunt, Joaquim
    Berger, Raanan
    Montgomery, Robert B.
    Heath, Karl
    Dolled-Filhart, Marisa
    Pathiraja, Kumudu
    Gause, Christine K.
    Cheng, Jonathan D.
    Perini, Rodolfo F.
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [22] A phase Ib study of everolimus combined with metformin for patients with advanced cancer
    Remco J. Molenaar
    Tim van de Venne
    Mariëtte J. Weterman
    Ron A. Mathot
    Heinz-Josef Klümpen
    Dick J. Richel
    Johanna W. Wilmink
    Investigational New Drugs, 2018, 36 : 53 - 61
  • [23] A phase Ib study of everolimus combined with metformin for patients with advanced cancer
    Molenaar, Remco J.
    van de Venne, Tim
    Weterman, Mariette J.
    Mathot, Ron A.
    Klumpen, Heinz-Josef
    Richel, Dick J.
    Wilmink, Johanna W.
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 53 - 61
  • [24] Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
    Mahalingam, Devalingam
    Wilkinson, Grey A.
    Eng, Kevin H.
    Fields, Paul
    Raber, Patrick
    Moseley, Jennifer L.
    Cheetham, Karol
    Coffey, Matt
    Nuovo, Gerard
    Kalinski, Pawel
    Zhang, Bin
    Arora, Sukeshi Patel
    Fountzilas, Christos
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 71 - 81
  • [25] Phase Ib/II Study of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of Lung Cancer Patients Receiving ≥ 1 Prior Line of Therapy
    Weiss, Glen J.
    Barndt, Heather
    Blaydorn, Lisa
    Sangal, Ashish
    Khemka, Vivek
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S742 - S743
  • [26] Results of the phase Ib study of NC410 combined with pembrolizumab in ovarian cancer patients
    Zsiros, E.
    Christenson, E. S.
    Sohal, D.
    Manda, S.
    Fu, S.
    Martz, A.
    Zika, M.
    Kordahi, S.
    Kothari, P.
    Kahan, S.
    Barbu, E. A.
    Morawski, A.
    Flies, D.
    Langermann, S. A. R.
    Chisamore, M.
    Guha, U.
    Myint, H.
    Mahadevan, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S575 - S575
  • [27] Pembrolizumab in patients with advanced cervical squamous cell cancer: Preliminary results from the phase Ib KEYNOTE-028 study.
    Frenel, Jean-Sebastien
    Le Tourneau, Christophe
    O'Neil, Bert H.
    Ott, Patrick Alexander
    Piha-Paul, Sarina Anne
    Gomez-Roca, Carlos Alberto
    Van Brummelen, Emilie
    Rugo, Hope S.
    Thomas, Shari
    Saraf, Sanatan
    Chen, Mei
    Varga, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Pembrolizumab in advanced endometrial cancer: Preliminary results from the phase Ib KEYNOTE-028 study.
    Ott, Patrick Alexander
    Bang, Yung-Jue
    Berton-Rigaud, Dominique
    Elez, Elena
    Pishvaian, Michael J.
    Rugo, Hope S.
    Puzanov, Igor
    Morgan, Mark Aloysuis
    Mehnert, Janice M.
    Aung, Kyaw Lwin
    Carrigan, Marion
    Saraf, Sanatan
    Chen, Mei
    Soria, Jean-Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
    Yarchoan, Mark
    Huang, Chiung-Yu
    Zhu, Qingleng
    Ferguson, Anna K.
    Durham, Jennifer N.
    Anders, Robert A.
    Thompson, Elizabeth D.
    Rozich, Noah S.
    Thomas, Dwayne L., II
    Nauroth, Julie M.
    Rodriguez, Christina
    Osipov, Arsen
    De Jesus-Acosta, Ana
    Le, Dung T.
    Murphy, Adrian G.
    Laheru, Daniel
    Donehower, Ross C.
    Jaffee, Elizabeth M.
    Zheng, Lei
    Azad, Nilofer S.
    CANCER MEDICINE, 2020, 9 (04): : 1485 - 1494
  • [30] A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma
    Gouda, Mohamed A.
    Stephen, Bettzy
    Tian, Yanyan
    Alshawa, Anas
    Onwugaje, Dilichukwu O. Chudy
    Albittar, Aya
    Yang, Yali
    Zarifa, Abdulrazzak
    Yilmaz, Bulent
    Gurses, Serdar
    Sprenger, Ashabari
    Derbala, Mohamed H.
    Brink, Amanda
    How, Jeffrey Andrew
    Moyers, Justin
    Piha-Paul, Sarina A.
    Hong, David S.
    Meric-Bernstam, Funda
    Patel, Sapna P.
    Oliva, Isabella Glitza
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2024, 7 (04) : 247 - 254
12345